Solna

• Study of Intravenous ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibros … Pending
  2024-518013-25-00 4 Idiopathic Pulmonary Fibrosis
• ProFertil Pending
  2024-518977-32-00 5 Breast Cancer, Acute Leukemia, Lymphomas (Hodgkin and non-Hodgkin) ans
• A study of safety, feasibility and immunologic response of transfering tumor infiltrating lymphocytes with or without dendritic cell vaccina … Pending
  2024-519060-40-00 3 Advanced metastatic malignant melanoma stage 3 or 4 with measurable le
• Safety of oral micronized progesterone versus norethisterone acetate in continuous combination with oral estrogen as menopausal hormone ther … Pending
  2024-520435-33-00 5 Climacteric symptoms
• DAREON®-Lung-1: A study in people with advanced small cell lung cancer to compare obrixtamig plus atezolizumab, carboplatin, and etoposide t … Pending
  2025-520565-51-00 5 small cell lung cancer
• NOCANO: Nivolumab as neoadjuvant immunotherapy for patients with Oral CANcer and identification of response-predictive biomarkers in tumour … Pending
  2025-521006-18-00 4 Oral squamous cell carcinoma (OSCC)
• A study to test different doses of BI 3923948 alone and in combination with an anti-PD-1 antibody in people with different types of advanced … Pending
  2025-521438-27-00 1 advanced, unresectable and/or metastatic solid tumors
• Crohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year Pending
  2025-521590-13-00 5 Moderately to Severely Active Crohn’s Disease
• Contrast Strategy In Fenestrated EndoVascular Aneurysm Repair Randomized Control Trial Pending
  2025-521795-58-00 11 Abdominal aortic aneurysm
• The REFINE study Pending
  2025-522133-66-00 5 Autoimmune Premature Ovarian Insufficiency
• Phase 1/2 study to investigate the safety and preliminary efficacy of GSK5460025 alone or in combination with other anti-cancer agents in dM … Pending
  2025-522318-21-00 7 Neoplasms, Colorectal
• An extension study to investigate the long-term safety and tolerability of itepekimab in adult participants with inadequately controlled chr … Pending
  2025-522983-33-00 5 Chronic rhinosinusitis with nasal polyps
• A Study of Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants with Unresectable Stage III NSCLC Pending
  2025-523576-23-00 5 Unresectable Stage III non-small cell lung cancer without progression
• A Study of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50% Pending
  2025-523586-18-00 5 Non-Small Cell Lung Cancer
• Patient Evaluation of OraFID, a New Medicine Dispenser and App for Flexilev minitablets Pending
  2025-524296-23-01 6 Parkinsons Disease
• A randomized, open-label, Phase III trial to assess the efficacy and safety of BupiZenge compared to lidocaine for pain associated with oral … Pending
  2025-524386-24-00 5 Head and neck cancer
• Long-term safety and efficacy evaluation of lunsekimig (SAR443765) in adult participants with moderate-to-severe asthma. Recruiting
  2025-522896-27-00 4 2026-05-11 Asthma
• A clinical study of sacituzumab tirumotecan in people with ovarian cancer (MK-2870-021) Recruiting
  2023-508047-40-00 5 2026-04-30 Ovarian cancer
• Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients with Colorectal, Gastric, … Recruiting
  2024-519384-18-00 10 2026-04-29 Colorectal, Gastric, Ovarian or Pancreatic Cancer
• AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer (TREVI-OC-01) Recruiting
  2025-520466-22-00 5 2026-04-29 Advanced Platinum-resistant Epithelial Ovarian Cancer
• A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB 3111) Compared With Venetoclax Plus Acalabrutinib in Patients With Pre … Recruiting
  2025-524366-21-00 5 2026-04-29 treatment-naive Chronic Lymphocytic Leukemia
• Adjunctive Hyperbaric Oxygen Treatment for Patients with Necrotizing Soft-Tissue Infection (HOT-NSTI trial) Recruiting
  2025-521368-37-00 6 2026-03-27 Necrotizing soft-tissue infection
• EMPEROR: A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen (STK-001) in Patients with Dravet Syndrome Recruiting
  2024-519555-28-00 5 2026-03-18 Dravet syndrome
• A Study to Evaluate Atumelnant in Adults with Congenital Adrenal Hyperplasia Recruiting
  2024-519579-24-00 5 2026-02-26 Classic Congenital Adrenal Hyperplasia

Showing 25–48 of 382 trials